Bioverativ Inc. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$1.2B

Net Income/Loss (FY2017)

$355.6M

Total Assets (FY2017)

$1.6B

Total Equity (FY2017)

$897.6M

Cash Flows from Operating Activities (FY2017)

$590.7M

Source: Bioverativ Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.